Instil Bio Inc.
TIL | NASDAQ
$7.07
-$0.02 (-0.28%)
Sep 21, 2026, 12:36 PM ET · Market open
Company Profile
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Key Executives
| Name | Position |
|---|---|
| Bronson Crouch | Chairman & Chief Executive Officer |
| Sandeep Laumas | Chief Financial Officer & Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 13, 2026 | 8-K | Current Report |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 11, 2026 | 8-K | Current Report |
| May 15, 2026 | 10-Q | Quarterly Report |
| May 15, 2026 | 8-K | Current Report |
| Apr 24, 2026 | ARS | Filing |
Instil Bio Inc.
| Country | United States |
| IPO Date | Mar 18, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Bronson Crouch |
Contact Details
3963 Maple Avenue Dallas,
Texas 75219 United States
Stock Details
| Ticker Symbol | TIL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001789769 |
| CUSIP Number | 45783C200 |
| ISIN Number | US45783C2008 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove TIL